MiCo BioMed Co., Ltd. (KOSDAQ:214610)
South Korea
· Delayed Price · Currency is KRW
499.00
-4.00 (-0.80%)
At close: Apr 4, 2025, 3:30 PM KST
MiCo BioMed Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
Apr '25 Apr 4, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Market Capitalization | 25,697 | 60,853 | 80,681 | 87,860 | 166,501 | 204,207 | |
Market Cap Growth | -24.58% | -24.58% | -8.17% | -47.23% | -18.46% | 148.32% | |
Enterprise Value | 33,331 | 73,659 | 100,389 | 97,164 | 156,031 | 213,436 | |
Last Close Price | 499.00 | 1397.00 | 1852.00 | 3081.22 | 5841.47 | 7221.60 | |
PS Ratio | 4.69 | 13.12 | 15.03 | 5.45 | 5.50 | 4.47 | |
PB Ratio | 0.84 | 2.35 | 2.22 | 4.98 | 3.19 | 3.65 | |
P/TBV Ratio | 3.14 | 3.14 | 2.61 | 5.32 | 3.27 | 3.71 | |
EV/Sales Ratio | 7.18 | 15.87 | 18.70 | 6.03 | 5.15 | 4.67 | |
EV/EBITDA Ratio | - | - | - | - | 40.72 | |
EV/EBIT Ratio | - | - | - | - | 61.59 | |
Debt / Equity Ratio | 0.83 | 0.83 | 0.38 | 1.32 | 0.42 | 0.12 | |
Debt / EBITDA Ratio | - | - | - | - | - | 1.28 | |
Asset Turnover | 0.08 | 0.08 | 0.09 | 0.22 | 0.38 | 0.95 | |
Inventory Turnover | 1.17 | 1.17 | 0.85 | 0.92 | 0.82 | 2.03 | |
Quick Ratio | 1.09 | 1.09 | 1.42 | 0.57 | 4.02 | 3.93 | |
Current Ratio | 1.89 | 1.89 | 2.70 | 1.33 | 5.94 | 6.46 | |
Return on Equity (ROE) | -90.33% | -90.33% | -95.59% | -111.40% | -19.57% | -20.29% | |
Return on Assets (ROA) | -23.72% | -23.72% | -21.02% | -22.17% | -8.50% | 4.51% | |
Return on Capital (ROIC) | -28.23% | -28.23% | -27.48% | -28.10% | -9.90% | 5.24% | |
Return on Capital Employed (ROCE) | - | - | - | - | - | 5.60% | |
Earnings Yield | -120.05% | -50.69% | -31.95% | -44.27% | -6.35% | -2.83% | |
FCF Yield | -45.34% | -19.15% | -14.56% | -17.79% | -6.87% | -11.97% | |
Buyback Yield / Dilution | -76.40% | -76.40% | -12.65% | -0.19% | -25.24% | -22.97% | |
Source: S&P Global Market Intelligence. Standard template.
Financial Sources.